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Laboratory mice have become the premier animal mo-
del for most human and domestic animal diseases, and
they have long been the model of choice for studying
mammalian genetics, especially since the advent of ge-
netic engineering. Many remarkable discoveries have
been made through intense study of these wonderful
small mammals, and undoubtably many more will be
made.1^2 It is no surprise that one mouse model for alo-
pecia areata (AA) has been found3 possibly many more
will be, some of which exhibit rare phenotypes found
in subpopulations of humans with the disease, such as nail
deformities, thyroid disease, in£ammatory bowel disease,
and autoimmune polyendocrine syndrome type 14^5
Intense investigation by many groups into the ¢rst
model, the adult onset form of AA (using the C3H/HeJ
inbred strain), found similarities as well as di¡erences
with commonly held ideas concerning human AA.
Regardless of some of the controversies, much insight
has been gained from studying these and other rodent
and domestic animal models which has opened up
new ideas and discussions of AA and its treatment.
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A
s with human AA, mice can lose hair only on their
head, patchy areas anywhere on their body, or essen-
tially all their hair with prolonged disease. Obvious
nail lesions, a rare feature in some humans with AA,
are seen only in one congenic strain (McElwee et al,
1999a). Microscopically, anagen-stage hair follicles are targeted in
all species a¡ected. A mixed in£ammatory response, consisting
primarily of T cells, is found in and around the hair follicle. In
humans, this is classically found in and around the bulb region;
in C3H/HeJ mice, it is found slightly above the bulb. In both spe-
cies, the in£ammation may extend up to the region of the sebac-
eous gland. In both species the location of the in£ammation
correlates directly with abnormal expression of major histocom-
patibility antigens, which explains biologically why there are spe-
cies-speci¢c morphological di¡erences. The T lymphocytes are
primarily CD4þ and CD8þ cells. In humans, the dogma is
that CD4þ cells are more prevalent than CD8þ cells. This is a
big di¡erence from the mouse, where this ratio can vary with
stage of disease. Initial testing of human tissue arrays using anti-
bodies speci¢c for these cell surface markers indicates that the hu-
man T cell ratio, as in the mouse, is highly variable between
individuals, suggesting that the ratio is not a reliable measure to
compare between species. This work is being expanded to do-
mestic animals (Sundberg and King, unpublished data; McElwee
et al, 1998b). In both rat and mouse models, depletion or trans-
plantation of either population does not result in full recovery
from or causation of disease, suggesting that both populations
are involved (McElwee et al, 1996; McElwee et al, 1999b; Carroll
et al, 2002). This has been con¢rmed in a xenograft model (Gilhar
et al, 2002). The humoral system has also been implicated in both
species, because autoantibodies are present in the sera (Tobin et al,
1994;Tobin et al, 1997). Gene array studies involving both sponta-
neous human AA and spontaneous or graft-induced mouse AA
reveal that the humoral response is very late and nonspeci¢c
(Carroll et al, 2002). However, these gene arrays provide evidence
supporting activation of the lymphocyte costimulatory cascade.
The C3H/HeJ Mouse Model The spontaneous C3H/HeJ
mouse model was di⁄cult to use initially because a¡ected mice
were found in colonies in relatively low frequency and there was
no easy way to determine what stage of disease they were in
(waxing or waning of lesions). Breeding studies revealed that
this was a complex polygenic trait (Sundberg et al, 1994). Simple
skin graft experiments revealed that full-thickness grafts of skin
with AA onto histocompatible, clinically normal mice would
induce onset of AA in a very predictable manner (McElwee et
al, 1998a). This provided both a means to test a variety of
hypotheses concerning the mechanisms involved and a more
reliable tool to test treatments. Blocking various stages of the
lymphocyte costimulatory cascade or surface markers on
lymphocytes that are involved with homing to the skin has
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revealed a general understanding of how lesions evolve
(Freyschmidt-Paul et al, 2000b; Carroll et al, 2002). Current ideas
for mechanisms involved in the skin graft model are summarized
in Fig. 1. Brie£y, AA is a complex polygenic trait in£uenced
by epigenetic (primarily environmental) events. An antigenic
epitope(s), as yet unknown, is recognized by antigen-presenting
cells. These cells have B7.1 (CD80) and B7.2 (CD86) lymphocyte
costimulatory molecules on their surface. Antigen-presenting
cells migrate to regional lymph nodes. A complex of B7.1 and
B7.2 ligands and CD28 T cell surface receptors in the presence
of antigen signal promotes T cell proliferation, enhances
cytokine production, and induces Bcl-x, which promotes T cell
survival (Carroll et al, 2002). T Cells with CD44var.10 surface
receptors migrate to the skin, homing in on hair follicles in the
anagen stage of the hair cycle, thus initiating the ¢rst stages of
clinical AA (Freyschmidt-Paul et al, 2000b). Subsequent studies
con¢rmed this and that other CD 44 variants are upregulated
early and then downregulated. CD44 is not involved with
maintenance of disease, and at early stages CD4þ /CD25þ
regulatory cells are at a low level (McElwee et al, 2002; Z˛ller
et al, 2002).
A persistent hypothesis for the pathogenesis of human AA
is that melanocytes or melanogenesis-related proteins are the
target(s) for the immune system based on the clinical
observation that white hair often regrows in human patients and
that it is resistant to future recurrences. White hair regrows in
grafts from mice with AA onto immunode¢cient mice and
in some of the spontaneous cases in C3H and B6 hybrids.
Induction of white hair by freeze-branding normal mice prior
to grafting, in which melanocytes were destroyed, indicated
that white hair was not spared and that this observation was the
result of injury and a secondary e¡ect (McElwee et al, 2001).
This conclusion is supported by the observation of AA-like
phenotypes in several albino strains (McElwee et al, 1999a). It
should be noted that albino mice (Tyrc) have melanosomes but
lack melanin because tyrosinase is not available to convert
tyrosine in two steps to dihydroxyphenylalanine-quinone,
which ultimately becomes melanin (Kwon et al, 1989). Late
upregulation of many melanogenesis-related genes in the mouse
graft model also suggests this may be a secondary event in the
pathogenesis of AA (Carroll et al, 2002). The Gilhar xenograft
model for relapsing AA also recently showed that no single
melanocyte antigen is generally associated with AA (Gilhar et al,
2001).
There is ample evidence that human AA has a complicated
genetic predisposition (reviewed in Sundberg et al, in press-b).
The same is true with the C3H/HeJ mouse model. Crosses
between C3H/HeJ mice with AA and C57BL/6J mice that never
get this disease were done. Over 1000 F2 females were evaluated.
Analyses revealed two regions of interest. The mouse chromo-
some^17 interval (LOD score 10.9) centers around H2 (human
HLA ortholog), but includes a number of other candidate genes.
The second interval, on mouse chromosome 9, is only suggestive
based on a LOD score of 2.0 (Sundberg et al, 2003).
A major value of the AA mouse graft model is the production
of a readily available, reproducible, and predictably induced
form of AA in mice for therapeutic screening studies. To date,
investigators have found comparable response patterns between
mice and humans with AA using intralesional steroids as well as
topical applications of diphencyprone, anthralin, and squaric acid
dibutyl ester (Sundberg et al, 1994; Freyschmidt-Paul et al, 1999;
Shapiro et al, 1999; Gardner et al, 2000). Experimental com-
pounds are now being tested as well (Freyschmidt-Paul et al, 2000a;
Tang et al, 2003a,b).
SUMMARY
The mouse has proven to be another tool with which to dissect
the pathogenesis of AA and to investigate new therapeutic ap-
proaches. Inbred animals, which include both the mouse and rat
models for AA, are essentially identical to each other within a
strain and therefore will most likely provide models for very spe-
ci¢c subsets of human AA. General comparisons between the
very speci¢c rodent diseases and the very pleomorphic human
diseases result in misunderstandings of how valuable these mod-
els really are. Regardless, data collected from all of the models
continue to provide much needed insight on how to deal with
human patients with AA.
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